Trials / Completed
CompletedNCT01167101
Is Rebamipide Effective on the Healing of Iatrogenic Gastric Ulcer After Endoscopic Mucosal Resection?
Is Rebamipide Effective on the Healing of Iatrogenic Gastric Ulcer After Endoscopic Mucosal Resection? : Multicenter, Randomized, and Prospective Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 290 (actual)
- Sponsor
- Kangdong Sacred Heart Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
Treatment strategy of post endoscopic submucosal dissection (ESD) ulcer is not yet conclusive. Rebamipide is a mucosal protective agent widely used in East Asia and has good effect on quality of ulcer healing (QOUH). The investigators will conduct this randomized controlled study to assess the effect of a combination therapy of rebamipide and proton pump inhibitor (PPI) on post ESD ulcer healing.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rebamipide | Rebamipide 100mg Tid for 28days |
| DRUG | pantoprazole | pantoprazole 40mg qd for 28days |
Timeline
- Start date
- 2009-05-01
- Primary completion
- 2010-12-01
- Completion
- 2010-12-01
- First posted
- 2010-07-22
- Last updated
- 2015-09-04
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01167101. Inclusion in this directory is not an endorsement.